Gilead Sciences, Inc. · NASDAQ:GILD
Bluestone Jeffrey sold 5,000 Gilead Sciences, Inc. shares (Form 4)
Traded Aug 20, 2026 · Filed Aug 21, 2026
On Aug 20, 2026, Bluestone Jeffrey (Director) sold 5,000 Gilead Sciences, Inc. shares at an average US$145.01 for US$725K under a trading plan, leaving 10,066 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$145.01 average (US$143.75 to US$146.36)
- Value
- US$725K
- Holding after
- 10,066 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | Option exercise | 1,165 | US$67.45 | 11,231 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 1,165 | US$143.75 | 10,066 | Direct |
| Aug 20, 2026 | Common Stock | Option exercise | 1,816 | US$67.45 | 11,882 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 1,816 | US$144.92 | 10,066 | Direct |
| Aug 20, 2026 | Common Stock | Option exercise | 1,658 | US$67.45 | 11,724 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 1,658 | US$145.73 | 10,066 | Direct |
| Aug 20, 2026 | Common Stock | Option exercise | 26 | US$67.45 | 10,092 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 26 | US$146.36 | 10,066 | Direct |
| Aug 20, 2026 | Common Stock | Option exercise | 335 | US$61.35 | 10,401 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 335 | US$146.26 | 10,066 | Direct |
Source
Related
- Gilead Sciences, Inc.
- Bluestone Jeffrey
- Gilead Sciences, Inc. shareholders
- Form 4 · Bluestone Jeffrey · May 4, 2026
- Form 4 · Mercier Johanna · Oct 16, 2026
- Form 4 · Dickinson Andrew D · Oct 16, 2026
- Form 4 · O'Day Daniel Patrick · Oct 2, 2026
- Form 4 · Burkhart Erin · Sep 23, 2026
- Form 4 · Mercier Johanna · Sep 16, 2026